A review of manufacturing records verified that the lot involved in this complaint met all pre-release specifications.The device remains implanted and was, therefore, not available for analysis.No clinical images enabling direct assessment of product performance were returned for evaluation.Cause of the reported event cannot be established based on the information reported to gore.Therefore, this investigation is considered complete.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
The following was reported to gore: on may 9, 2022 a 6mm gore-tex® stretch vascular graft was implanted as part of a bypass between the left subclavian artery and the left common carotid artery.The patient was further treated with a gore® tag® thoracic branch endoprostheses (tbe) in zone 1.On (b)(6) 2022 during the patient's one month follow up, it was noticed that the graft had occluded.A bilateral upper extremity and lower extremity arterial doppler were performed.The left upper extremity arterial doppler shows left subclavian arterial disease with moderate flow reduction to the wrist.The physician evaluated the patient with no intervention necessary.It was noticed that the patient's decreased flow in the left subclavian is consistent with the known occlusion of the left carotid stent that was identified outpatient.
|